alzheimer-disease

Documents about alzheimer-disease

• Predicting categorical and continuous Alzheimer's disease outcomes from a single MRI scan.#218805NCBI PubMed Central
• Influence of an AQP4 haplotype and sleep duration on early Alzheimer's disease.#265292NCBI PubMed Central
• Tunable acoustic rotation for deep biophysical phenotyping of preclinical Alzheimer's disease.#266942NCBI PubMed Central
• Smartphone-based detection of subtle memory decline in prodromal Alzheimer's disease#273297Europe PMC
• Mechanisms of increased Alzheimer's disease pathology with R47H and R62H TREM2 variants.#284882NCBI PubMed Central
• Direct RNA Sequencing reveals epitranscriptomic regulation of brain cells and Alzheimer's Disease pathology#287239bioRxiv / medRxiv
• Early Gut Microbiome Alterations in Mild Cognitive Impairment Reflect Changes in Alzheimer Disease.#297144NCBI PubMed Central
• Adaptive neighborhood aggregation graph neural network for early diagnosis of Alzheimer's disease.#297188NCBI PubMed Central
• Redirecting Alzheimer's disease therapeutics: Multitarget drugs and complementary non-pharmacological strategies.#312379NCBI PubMed Central
• The Utility of Speech and Language Analytics for Screening Alzheimer's Disease.#315801NCBI PubMed Central
• Clinical Impact and Prognostic Value of Alzheimer Disease Biomarkers in the Very Old.#322862NCBI PubMed Central
• Investigating causal associations among inflammatory proteins, blood metabolites, and Alzheimer's disease risk.#322992NCBI PubMed Central
• Development of a serum-based microRNA panel for Alzheimer's disease diagnosis.#334740NCBI PubMed Central
• Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.#340273NCBI PubMed Central
• Lymphoid-like Suppressive Microglia in Alzheimer's Disease: A New Neuroimmune Regulatory Axis?#367991NCBI PubMed Central
• Alzheimer's disease: A comprehensive review of epidemiology, pathophysiology, diagnosis, and treatment.#371445NCBI PubMed Central
• Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease#384239CiNii
• Abnormal hippocampo-cortical theta-gamma phase-amplitude coupling in Alzheimer’s disease#422492Europe PMC
• Generalized Multilevel Multisource Functional Regression With an Application to Alzheimer's Disease.#431006NCBI PubMed Central
• Advancements in non-pharmaceutical interventions for Alzheimer's disease management: an update review.#433762NCBI PubMed Central
• Thalamic volume alterations mediate glymphatic function and cognitive dysfunction in Alzheimer's disease.#436861NCBI PubMed Central
• Ferroptosis-related biomarkers for diagnosis and mechanistic insights into Alzheimer's disease.#437026NCBI PubMed Central
• Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease.#438938NCBI PubMed Central
• Clinical-biological Alzheimer's disease stage concordance: insights from cohorts and autopsy data.#442868NCBI PubMed Central
• Mental health and gut-brain crosstalk: implications for depression and Alzheimer's disease.#455133NCBI PubMed Central
• What Do Persistent Misclassifications Tell Us About Alzheimer's Disease Detection using Structural MRI?#463564bioRxiv / medRxiv
• Mapping Amyloid-PET Uptake in the White Matter in Alzheimer’s Disease#475680Europe PMC
• Functional assessment improves discrimination of clinical and biomarker-defined Alzheimer’s disease#475740Europe PMC
• Genetic ablation of neuronal mitochondrial calcium uptake impedes Alzheimer's disease progression#478595Europe PMC
• Beyond the Cochrane review: Re-evaluating anti-amyloid therapy in Alzheimer's disease.#479178NCBI PubMed Central
• Single-cell multiomics connects 3D genome and transcriptome alterations in Alzheimer's disease.#480783NCBI PubMed Central
• Indices of Arterial Stiffness and the Alzheimer s Disease Biomarker, p-tau217, in Non-Demented Midlife Women#357806ScholarBank@NUS
• A comprehensive assessment of cholinesterase inhibitors for the treatment of Alzheimer’s disease based on drug selection recommendations for Chinese Medical Institutions#436111Figshare
• 42 U.S.C. § 247a — Family support groups for Alzheimer’s disease patients#595353US Code (LII)
• Efeitos do programa AD-HOMEX nas funções cognitivas, no controle postural e desempenho funcional de idosos com doença de Alzheimer: um ensaio clínico randomizado e controlado#313285RI UFSCar
• Interactions fonctions exécutives et langage chez des locuteurs bilingues : apport des tests de fluence verbale#274261HAL (France)
• Indole Metabolites as Modulators of Human Cholinesterases: A Kinetic and Molecular Docking Study with Comparison to Alzheimer's Drugs#315267Muğla Sıtkı Koçman University Institutional Repository
• Associations between serum estradiol and estrone and Alzheimer's disease biomarkers: an analysis in female participants from the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS)#319784bioRxiv / medRxiv
• Resting-State EEG Alpha Rhythms Are Related to CSF Tau Biomarkers in Prodromal Alzheimer's Disease#185646IRIS
• Theoretical impact of a mobile team dedicated to patients with Alzheimer’s disease and related dementias on medication exposure in community-dwelling older patients (MEMORIAS study)#374428HAL (France)
• PREreview of "Astrocyte-neuron mitochondrial transfer via mitoEVs supports neuronal energy metabolism and is impaired in early Alzheimer's disease"#432352Zenodo (CERN)
• Rewiring mTOR signaling in Alzheimer's disease: emerging mTOR modulators beyond oncology#273312Europe PMC
• Contextual variability in under-diagnosed cardiometabolic disease and cognitive vulnerability among populations at high risk for Alzheimer’s disease and related dementias.#298749NCBI PubMed Central
• Probing the Roles of Connexin 43 Hemichannels in a Mouse Model of Alzheimer's Disease#176225DigitalCommons@USU
• Promotores program to increase Hispanic/Latino(a) participation in Alzheimer's disease research.#4116NCBI PubMed Central
• Olfactory decline tracks central-to-peripheral spread of tau pathology in Alzheimer's disease.#13431NCBI PubMed Central
• Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias.#13604NCBI PubMed Central
• Dynamic Alterations of Functional Systems in Alzheimer's Disease: A Co-Activation Pattern Analysis.#14856NCBI PubMed Central
• Cognitive and Brain Reserve as Modifiers of Early Alzheimer Disease-Related Cognitive Vulnerability.#30873NCBI PubMed Central
• Reprogramming aging astrocytes in Alzheimer's disease#120649Zenodo (CERN)